← All stocks

Theravance Biopharma, Inc.

TBPH Scheduled selling only

CIK 0001583107 #2645 in the set updated 21 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$226.79K

$226.79K on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 3 sales

Net

−$226.79K

$0.00 against sales at will

By person

13 insiders · 3 transactions

26.5×

Rick E Winningham holds 26.5 times base salary in stock. $27.84M of shares against $1.05M in salary for 2025.

Salary from the company's own proxy. The shares are what Rick E Winningham last reported holding, valued at $17.03, the price Ordinary Shares was last bought or sold at on the open market here, on 15 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

—

$226.79K (3) scheduled

−$226.79K

213,476

0.4112%

$3.64M

−34.7%

Samaha Eli

10% owner

—

9,174,453

17.67%

$156.28M

−3.5%

Winningham Rick E

CHIEF EXECUTIVE OFFICER

—

1,634,422

3.15%

$27.84M

−10.6%

Grimaud Brett A.

SVP, GEN COUNSEL AND SECRETARY

—

355,168

0.6841%

$6.05M

+3.7%

Sawaf Aziz

SVP & CHIEF FINANCIAL OFFICER

—

336,841

0.6488%

$5.74M

+4.8%

Miller Aine

SVP, DEV & HEAD OF IRE OFFICE

—

189,826

0.3656%

$3.23M

+18.2%

MITCHELL DEAN J

Director

—

97,213

0.1872%

$1.66M

+20.7%

Smaldone Alsup Laurie

Director

—

80,989

0.1560%

$1.38M

+25.9%

O'Connor Donal

Director

—

80,213

0.1545%

$1.37M

+26.2%

PAKIANATHAN DEEPIKA

Director

—

64,074

0.1234%

$1.09M

+35.1%

GRAY SUSANNAH

Director

—

48,146

0.0927%

$820.13K

+52.9%

BROSHY ERAN

Director

—

44,703

0.0861%

$761.48K

−63.5%

Grant Jeremy T

Director

—

32,954

0.0635%

$561.35K

+47.7%

Theravance Biopharma, Inc.

By person

Individual transactions

What was left out